| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0269881105056530 |
| P698 | PubMed publication ID | 16166186 |
| P50 | author | Hans-Jürgen Möller | Q1577771 |
| Thomas Frodl | Q43251763 | ||
| P2093 | author name string | Hahn K | |
| Dresel S | |||
| Meisenzahl EM | |||
| La Fougère C | |||
| Schmitt GJ | |||
| P2860 | cites work | Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. | Q51413531 |
| Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. | Q51418888 | ||
| Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. | Q52021168 | ||
| Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. | Q52506986 | ||
| Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. | Q55034390 | ||
| Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 | ||
| Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. | Q31861860 | ||
| Increased dopamine transmission in schizophrenia: relationship to illness phases | Q33679807 | ||
| The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders | Q34435130 | ||
| Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats | Q34449086 | ||
| Elevated dopa decarboxylase activity in living brain of patients with psychosis | Q35927690 | ||
| Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method | Q36050571 | ||
| 123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia | Q42455246 | ||
| Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. | Q43700709 | ||
| Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent | Q43715446 | ||
| Striatal dopamine transporters and cognitive functioning in healthy men and women | Q43726221 | ||
| Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia | Q43762657 | ||
| Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia | Q43762659 | ||
| Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys | Q44044333 | ||
| Dopamine transporter change in drug-naı̈ve schizophrenia: an imaging study with 99mTc-TRODAT-1 | Q44659275 | ||
| Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study | Q45001453 | ||
| Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. | Q48121459 | ||
| Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents. | Q48522155 | ||
| Imaging D2 receptor occupancy by endogenous dopamine in humans | Q48632608 | ||
| Presynaptic dopaminergic function in the striatum of schizophrenic patients | Q48802317 | ||
| Brain dopamine transporter: gender differences and effect of chronic haloperidol. | Q51044944 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| striatum | Q1319792 | ||
| P304 | page(s) | 488-493 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. | |
| P478 | volume | 19 |
| Q91619609 | Altered levels of dopamine transporter in the frontal pole and dorsal striatum in schizophrenia |
| Q33866125 | Classics in Chemical Neuroscience: Aripiprazole. |
| Q46693337 | DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents |
| Q44568973 | Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients |
| Q33662831 | In SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology. |
| Q34703195 | Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials |
| Q34415890 | Presynaptic regulation of dopamine transmission in schizophrenia |
| Q36621010 | Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis |
| Q46801461 | Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients |
| Q34042175 | Study of childhood onset schizophrenia (COS) using SPECT and neuropsychological assessment |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q34658860 | The role of dopamine for the pathophysiology of schizophrenia |
Search more.